Clinical Trial Update: Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating telmisartan 80 mg plus hydrochlorothiazide 25 mg as first-line therapy for moderate to severe hypertension; the study is completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• Micardis (telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2011-05-24